Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Interactions of Ligands with Morphine and Enkephalin Receptors are Differentially Affected by Guanine Nucleotide

KWEN-JEN CHANG, ELI HAZUM, ANTHONY KILLIAN and PEDRO CUATRECASAS
Molecular Pharmacology July 1981, 20 (1) 1-7;
KWEN-JEN CHANG
Department of Molecular Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELI HAZUM
Department of Molecular Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTHONY KILLIAN
Department of Molecular Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PEDRO CUATRECASAS
Department of Molecular Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effects of cations and GTP on morphine (µ) and enkephalin (δ) receptors were examined by using binding assays of [3H]naloxone to rat brain membrane preparations and [3H]diprenorphine or [3H]naloxone to neuroblastoma cell membranes. The potencies and Hill coefficients (n) of many opiate agonists and opioid peptides in competing with the binding of the labeled antagonist are reduced by Na+ (100 mM) and GTP (0.1 mM). These effects are qualitatively similar for both subtypes of opiate receptors. However, quantitatively, the effects of GTP are much more profound for morphine receptors than for enkephalin receptors and the effects of Na+ are dependent upon the type of labeled antagonist used rather than upon receptor type. Na+ does not alter the affinity of opiate antagonists. GTP reduces the affinity of naloxone to morphine-binding sites by a factor of 2.5. Mg2+ (5 mM) increases the potency of opiate agonists and enkephalins for both receptor sites. The combination of Na+, GTP, and Mg2+ further reduces the affinity of enkephalins and opiate agonists for enkephalin-binding sites and the affinity of Met- and Leu-enkephalin for morphine-binding sites. However, the combination of Na+, GTP, and Mg2+ partially restores the affinity of [D-Ala2, Leu5]- and [D-Ala2, D-Leu5]enkephalin and morphine for the morphine-binding sites. These differential effects of cations and nucleotide further emphasize the differences that exist between morphine and enkephalin receptors and indicate the complex interactions of cations and nucleotides with opiate-binding sites.

ACKNOWLEDGMENTS The technical assistance of Mark Collins is gratefully acknowledged. We thank Lydia Hernaez for assistance in growing the neuroblastoma cells.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 1
1 Jul 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interactions of Ligands with Morphine and Enkephalin Receptors are Differentially Affected by Guanine Nucleotide
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interactions of Ligands with Morphine and Enkephalin Receptors are Differentially Affected by Guanine Nucleotide

KWEN-JEN CHANG, ELI HAZUM, ANTHONY KILLIAN and PEDRO CUATRECASAS
Molecular Pharmacology July 1, 1981, 20 (1) 1-7;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Interactions of Ligands with Morphine and Enkephalin Receptors are Differentially Affected by Guanine Nucleotide

KWEN-JEN CHANG, ELI HAZUM, ANTHONY KILLIAN and PEDRO CUATRECASAS
Molecular Pharmacology July 1, 1981, 20 (1) 1-7;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics